e-learning
resources
Vienna 2009
Sunday, 13.09.2009
Oxygen, end-of-life and care for chronic respiratory patients
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Homefill II oxygen concentrator system – ²better for your patient and your pocket²
P. Murphie, S. Little, J. Gysin, P. Rafferty (Dumfries, United Kingdom)
Source:
Annual Congress 2009 - Oxygen, end-of-life and care for chronic respiratory patients
Session:
Oxygen, end-of-life and care for chronic respiratory patients
Session type:
Thematic Poster Session
Number:
590
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Murphie, S. Little, J. Gysin, P. Rafferty (Dumfries, United Kingdom). Homefill II oxygen concentrator system – ²better for your patient and your pocket². Eur Respir J 2009; 34: Suppl. 53, 590
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
European Respiratory Society guideline on long term management of children with bronchopulmonary dysplasia
PP306 – Submicroscopic changes of type I alveolocytes in the early stages of experimental diabetes mellitus
Related content which might interest you:
Airway resistances: R
aw
, sR
aw
, sR
eff
– Which is the best determinant of airway function?
Source: Annual Congress 2010 - Lung function from infancy to adulthood
Year: 2010
Over-reading spirometry – Man or machine?
Source: Annual Congress 2011 - Quality control in lung function and exercise-related issues
Year: 2011
LungPoint® – A new approach to peripheral lung lesions
Source: Annual Congress 2010 - Tissue is mostly the issue: diagnostic and therapeutic bronchoscopy
Year: 2010
The results of drug resistance survey of MDR-strains on second line drugs obtains in national reference laboratory – " M.Nasta " Institute – Bucharest
Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2011
Triple 0 – A new respiratory syndrome?
Source: Annual Congress 2012 - Advanced experience with long-term noninvasive ventilation and late-breaking abstracts
Year: 2012
T spot TB reactivity – ²to treat or not to treat²
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009
Documentation & accuracy of smoking status – An educational need?
Source: Annual Congress 2011 - Smoking cessation science and smoking-related disorders
Year: 2011
Optimization of inhalation treatment – Evaluation of influence of PNEUMOlogic® and Optimiser® spacers on aerosol particle distribution from pMDI-EB
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I
Year: 2011
Ways to shorten the lung clearance index measurement ΙΙ – How long to wash?
Source: Annual Congress 2012 - New developments in paediatric respiratory physiology
Year: 2012
Usability evaluation of NEXThaler® versus Diskus® and Turbuhaler®
Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma
Year: 2012
Comparative
in vitro
performance of a new re-usable breath-actuated nebulizer (BAN) with other high performance systems intended for domiciliary use – 2: Portable battery-compressor
Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs
Year: 2012
Freeflowmetry – The new method of evaluation of the respiratory function phenotype
Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases
Year: 2011
Clinical significance of
Mycobacterium lentiflavum
– An emerging pathogen found in potable water
Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis
Year: 2010
Respiratory intermediate care unit (RICU) – What are we doing?
Source: Annual Congress 2011 - Noninvasive ventilation in the acute setting: education, organisation, H1N1, paediatrics, weaning, diagnostic procedures and special considerations
Year: 2011
Patient assessments of ease of use of Genuair® versus Aerolizer® and HandiHaler®
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Year: 2011
Transcutaneous measurement of pCO
2
(p
tc
CO
2
): Time delay from change in alveolar pCO
2
to first response in p
tc
CO
2
Source: Annual Congress 2011 - Sleep and weight: heavy under pressure
Year: 2011
Evaluation of difficult asthma – a single centre experience
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009
Comparative
in vitro
performance of a new re-usable breath-actuated nebulizer (BAN) with other high performance systems intended for domiciliary use – 1: Table-top compressors
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012
Patients‘ knowledge about inhalation therapy in pulmology – One year after intervention
Source: Annual Congress 2011 - Medical education
Year: 2011
Evaluation of pulmonary diffusion: TL
CO
or K
CO
?
Source: Annual Congress 2010 - Advances in lung function I
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept